An ELISA for the quantitation of von Willebrand Factor: Osteoprotegerin complexes in plasma

Thrombosis Research

Volumn 131, Issue 5, 2013, Pages 396-400

  Vinholt, Pernille J ^a   Overgaard, Martin ^a,b   Diederichsen, Axel C P ^a   Mickley, Hans ^a   Poulsen, Tina S ^a   Sand, Niels Peter R ^b,c   Nybo, Mads ^a   Rasmussen, Lars M ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c SVS Esbjerg ^*  (Denmark)

Author keywords

cardiovascular disease; Osteoprotegerin; Sandwich ELISA; von Willebrand factor

Indexed keywords

OSTEOPROTEGERIN; VON WILLEBRAND FACTOR;

ADULT; ANTIBODY DETECTION; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PLASMA; PRIORITY JOURNAL; VASCULAR SURGERY;

AGED; CARDIOVASCULAR DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84877776391     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.03.001     Document Type: Article

References (17)

1. A.C. Zannettino, C.A. Holding, P. Diamond, G.J. Atkins, P. Kostakis, and A. Farrugia Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor J Cell Physiol 204 2005 714 723
2. M. Baud'huin, L. Duplomb, S. Teletchea, C. Charrier, M. Maillasson, and M. Fouassier Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival J Biol Chem 284 2009 31704 31713
3. S. Shahbazi, P.J. Lenting, C. Fribourg, V. Terraube, C.V. Denis, and O.D. Christophe Characterization of the interaction between von Willebrand factor and osteoprotegerin J Thromb Haemost 5 2007 1956 1962
4. S.M. Venuraju, A. Yerramasu, R. Corder, and A. Lahiri Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity J Am Coll Cardiol 55 2010 2049 2061
5. A. Quercioli, F. Montecucco, M. Bertolotto, L. Ottonello, A. Pende, and F. Mach Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling Eur J Clin Invest 40 2010 645 654
6. M. Nybo, and L.M. Rasmussen The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review Eur J Endocrinol 159 2008 603 608
7. A.O. Spiel, J.C. Gilbert, and B. Jilma von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes Circulation 117 2008 1449 1459
8. P.J. Lenting, C. Casari, O.D. Christophe, and C.V. Denis Von Willebrand factor: the old, the new and the unknown J Thromb Haemost 10 2012 2428 2437
9. M.E. Chollet, J.P. Brouland, C. Baldit Sollier, F. Bauduer, L. Drouet, and S. Bellucci Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets Br J Haematol 148 2010 805 807
10. Saaby L, Poulsen TS, Hosbond S, Larsen TB, Diederichsen ACP, Hallas J, et al., Classification of myocardial infarction: Frequency and features of type 2 myocardial infarction. Am J Med 2013, in print.
11. K. Thygesen, J.S. Alpert, H.D. White, A.S. Jaffe, F.S. Apple, and M. Galvani Universal definition of myocardial infarction Circulation 116 2007 2634 2653
12. A.C. Diederichsen, N.P. Sand, B. Norgaard, J. Lambrechtsen, J.M. Jensen, and H. Munkholm Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study Eur J Prev Cardiol 19 2012 558 564
13. D. Green, B. McMahon, N. Foiles, and L. Tian Measurement of hemostatic factors in EDTA plasma Am J Clin Pathol 130 2008 811 815
14. B.Y. Chan, K.A. Buckley, B.H. Durham, J.A. Gallagher, and W.D. Fraser Effect of anticoagulants and storage temperature on the stability of receptor activator for nuclear factor-kappa B ligand and osteoprotegerin in plasma and serum Clin Chem 49 2003 2083 2085
15. N. Bucay, I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, and C. Capparelli Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1998 1260 1268
16. C.R. Dhore, J.P. Cleutjens, E. Lutgens, K.B. Cleutjens, P.P. Geusens, and P.J. Kitslaar Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques Arterioscler Thromb Vasc Biol 21 2001 1998 2003
17. M. Olesen, V. Skov, M. Mechta, B.H. Mumm, and L.M. Rasmussen No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells Mol Cell Endocrinol 362 2012 149 156